AZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer
Clinical trial NCT04525391 · TERMINATED
Trial details
- NCT number
- NCT04525391
- Sponsor
- Se-Hoon Lee
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-18
- Primary completion
- 2022-01-14
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.